Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS): A Randomized Placebo-controlled Trial

NCT02856594 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02856594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02856594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS): A Randomized Placebo-controlled Trial
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
March 6, 2017
Completion date
February 16, 2022
Enrollment
469 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, postoperative delirium, sleep